Related Articles

News
STAT+: Christi Shaw, leader of Gilead’s cancer cell therapy unit, to depart
February 17, 2023
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Christi Shaw, leader of Gilead’s cancer cell therapy unit, to depart
Shaw, who took the CEO role in July 2019, was inspired to join Kite in part by the experience of watching her sister fight cancer. […]

News
STAT+: Four brain-computer interface companies you should watch (other than Neuralink)
July 25, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Four brain-computer interface companies you should watch (other than Neuralink)
Elon Musk’s Neuralink has been the buzz of Silicon Valley and beyond. But it’s hardly the only company developing “brain-computer interfaces.” […]

News
STAT+: Pharmalittle: Biden plan to stretch monkeypox vax supplies hits problems; Pfizer and BioNTech ask FDA to clear Covid shot for variants
August 23, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Pharmalittle: Biden plan to stretch monkeypox vax supplies hits problems; Pfizer and BioNTech ask FDA to clear Covid shot for variants
The Pfizer-BioNTech booster shot targets the original coronavirus plus the BA.4 and BA.5 subvariants of Omicron, which have become predominant in the U.S. […]